Assessing clinical trial designs in advancing novel immunotherapeutic drugs
25 Sep 2025
Clinical Development
- Evaluating adaptive trial designs to accelerate immunotherapy development
- Balancing safety and efficacy endpoints in early-phase trials
- Integrating biomarkers for patient stratification and response prediction
- Addressing challenges in translating preclinical success to clinical outcomes
Industry Expert
